Bioprocess Containers Global Market Report 2024

Bioprocess containers are single-use containers utilized for critical sterile liquid-handling applications in the biopharmaceutical industry. They are employed for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products generated from manufacturing processes.

The main types of bioprocess containers include 2D bioprocess containers, 3D bioprocess containers, tank liners, and other containers and accessories. The 2D bioprocess container refers to containers with a two-dimensional design for sterile liquid handling. They are designed for small, simple BPCs ranging from 50 ML to 50 L. These containers are created from two sheets of film, heat-sealed around the perimeter to form a pillow-shaped chamber. Bioprocess containers find applications in biopharmaceutical companies, life science R&D companies, and others for upstream and downstream processes, as well as product development applications.

The bioprocess containers market research report is one of a series of new reports that provides bioprocess containers market statistics, including bioprocess containers industry global market size, regional shares, competitors with a bioprocess containers market share, detailed bioprocess containers market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess containers industry. This bioprocess containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioprocess containers market size has grown exponentially in recent years. It will grow from $4.15 billion in 2023 to $5.24 billion in 2024 at a compound annual growth rate (CAGR) of 26.2%. The historic growth in the bioprocess container industry can be attributed to the expansion of the biopharmaceutical industry, increased government investments in research and development, the rise in the privatization of laboratory services, and an overall increase in healthcare spending.

The bioprocess containers market size is expected to see exponential growth in the next few years. It will grow to $13.72 billion in 2028 at a compound annual growth rate (CAGR) of 27.2%. The forecasted growth in the bioprocess container industry can be attributed to increasing healthcare investments, expanding into emerging markets, regulatory support, and a rise in disposable income. Major trends in the forecast period include a focus on sustainability and eco-friendly solutions, the integration of digitalization and data analytics, a growing trend towards outsourcing and contract manufacturing, the adoption of customization and modular systems, and an emphasis on personalized medicine and patient-centric manufacturing.

The expansion of biopharmaceutical research and development (R&D) activities is a primary driver for the growth of the bioprocess containers market. The evolution of traditional drug development methods in biopharmaceutical R&D aims to expedite the delivery of medicines to patients, reduce operational costs, and enhance decision-making through the integration of data, digital technologies, and artificial intelligence (AI). According to an institutional report by IQVIA in February 2022, the global biopharmaceutical industry is witnessing robust growth, with over 6,000 products in active development. As the biopharmaceutical landscape continues to flourish, there is a concurrent surge in the demand for bioprocess containers to ensure the safe and uncontaminated handling and transportation of these critical products. This underscores the integral role of bioprocess containers in supporting the momentum of biopharmaceutical R&D.

Anticipated growth in the demand for biologics and biosimilars is poised to drive the bioprocess containers market. These innovative medications, used for various medical conditions, are witnessing increased adoption. Bioprocess containers, particularly those tailored for single-use applications, present notable advantages in terms of flexibility, scalability, cost-effectiveness, and reduced contamination risks. The Pharmaceutical Research and Manufacturers of America (PHRMA) reported in 2022 that 40 biosimilars have received approval, with 27 currently available in the United States. As the competition between biosimilars and biologic brands intensifies, the need for efficient and secure bioprocess containers grows. This trend is expected to shape the trajectory of the bioprocess container market in response to the expanding demand and usage of biologics and biosimilars.

A prominent trend in the bioprocess container market is the increasing focus on technological advancements by major industry players. These companies are actively incorporating next-generation technologies, including depth filtration, disposable chromatography, sterile filtration, ultrafiltration (UF)/defiltration (DF), and virus filtration, into their product offerings. This strategic emphasis on technological innovation aims to meet the evolving demands of the industry and strengthen market positions. Thermo Fisher Scientific, a US-based analytical laboratory instrument manufacturing company, exemplified this approach by introducing CentriPAK BPC in February 2021. This bioprocess container, designed for use with the Sorvall BIOS 16 centrifuge, ensures closed-system handling of sterile liquids, providing unparalleled sample protection from contamination and contributing to enhanced laboratory productivity.

Leading companies in the bioprocess container market are actively engaged in the development of innovative products, such as flexible single-use systems, to cater to a broader customer base, drive increased sales, and boost overall revenue. Flexible single-use systems, also known as single-use technologies (SUT) or disposable systems, play a crucial role in bioprocessing equipment designed for one-time use in the production and processing of biopharmaceuticals, encompassing biologics and vaccines. An exemplar of this trend is Single Use Support, an Austrian-based provider of process solutions in biopharmaceutical fluid management, which introduced the IRIS Single-Use Bag Line bioprocess container in October 2022. This solution offers flexibility and customization for bioprocessing and cryopreservation of biologics, cell and gene therapies, with attributes such as minimal extractables and leachables, ensuring the highest integrity even at temperatures as low as -150°C (-238°F). Its reliability and safety make it a preferred option for the transportation and storage of liquids.

A strategic move to enhance capabilities in the bioprocess container market is evident in the acquisition undertaken by Avantor Inc., a US-based chemicals and materials company. In June 2021, Avantor acquired RIM Bio for an undisclosed amount, positioning itself to better serve customers through the expansion of single-use manufacturing, distribution, and cleanroom capabilities in the AMEA (Asia-Pacific, Middle East, and Africa) region. RIM Bio, based in the US, specializes in providing a comprehensive range of single-use products, including 2D bags, 3D bags, tank liners, bag assemblies, and multi-bag manifolds. This strategic acquisition underscores the industry's commitment to meeting the evolving needs of the market and aligning with the increasing demand for flexible and efficient single-use systems in bioprocessing.

Major companies operating in the bioprocess containers market include Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group PLC, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMÜ Group, GVS Group Ltd., Integra Companies, Kuhner AG, L.B. Bohle Maschinen + Verfahren GmbH, Raith GmbH

North America was the largest region in the bioprocess containers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bioprocess containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The bioprocess containers market consists of sales of Standard BioProcess Containers, Bioprocessing Films, Fluid Transfer Solutions, and Retention Devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.